These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11259808)

  • 1. The methylenetetrahydrofolate reductase gene polymorphism in Koreans with coronary artery disease.
    Kim CH; Hwang KY; Choi TM; Shin WY; Hong SY
    Int J Cardiol; 2001 Mar; 78(1):13-7. PubMed ID: 11259808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease.
    Christensen B; Frosst P; Lussier-Cacan S; Selhub J; Goyette P; Rosenblatt DS; Genest J; Rozen R
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):569-73. PubMed ID: 9102178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction.
    Girelli D; Friso S; Trabetti E; Olivieri O; Russo C; Pessotto R; Faccini G; Pignatti PF; Mazzucco A; Corrocher R
    Blood; 1998 Jun; 91(11):4158-63. PubMed ID: 9596662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
    Hanson NQ; Aras O; Yang F; Tsai MY
    Clin Chem; 2001 Apr; 47(4):661-6. PubMed ID: 11274015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
    Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians.
    Ma J; Stampfer MJ; Hennekens CH; Frosst P; Selhub J; Horsford J; Malinow MR; Willett WC; Rozen R
    Circulation; 1996 Nov; 94(10):2410-6. PubMed ID: 8921781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of a common mutation in methylenetetrahydrofolate reductase to plasma homocysteine and early onset coronary artery disease.
    Dunn J; Title LM; Bata I; Johnstone DE; Kirkland SA; O'Neill BJ; Zayed E; MacDonald MC; Dempsey G; Nassar B
    Clin Biochem; 1998 Mar; 31(2):95-100. PubMed ID: 9622772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between methylenetetrahydrofolate reductase gene polymorphism 677C-->T and serum folate levels in determining hyperhomocysteinemia in heart transplant recipients.
    Potena L; Grigioni F; Viggiani M; Magnani G; Sorbello S; Falchetti E; Sassi S; Mantovani V; Bacchi-Reggiani L; Magelli C; Branzi A
    J Heart Lung Transplant; 2001 Dec; 20(12):1245-51. PubMed ID: 11744407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of six methylenetetrahydrofolate reductase (MTHFR) genotypes resulting from common polymorphisms: impact on plasma homocysteine levels and development of coronary artery disease.
    Meisel C; Cascorbi I; Gerloff T; Stangl V; Laule M; Müller JM; Wernecke KD; Baumann G; Roots I; Stangl K
    Atherosclerosis; 2001 Feb; 154(3):651-8. PubMed ID: 11257266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase 677 C-->T mutation and coronary heart disease risk in UK Indian Asians.
    Chambers JC; Ireland H; Thompson E; Reilly P; Obeid OA; Refsum H; Ueland P; Lane DA; Kooner JS
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2448-52. PubMed ID: 11073851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease.
    Kluijtmans LA; Kastelein JJ; Lindemans J; Boers GH; Heil SG; Bruschke AV; Jukema JW; van den Heuvel LP; Trijbels FJ; Boerma GJ; Verheugt FW; Willems F; Blom HJ
    Circulation; 1997 Oct; 96(8):2573-7. PubMed ID: 9355896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase (MTHFR) 677C>T and methionine synthase reductase (MTRR) 66A>G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid.
    Brilakis ES; Berger PB; Ballman KV; Rozen R
    Atherosclerosis; 2003 Jun; 168(2):315-22. PubMed ID: 12801615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
    Lim PS; Hung WR; Wei YH
    Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma homocysteine, methylenetetrahydrofolate reductase genotypes, and age at onset of symptoms of myocardial ischemia.
    Mager A; Battler A; Birnbaum Y; Magal N; Shohat M
    Am J Cardiol; 2002 Apr; 89(8):919-23. PubMed ID: 11950428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis.
    Verhoeff BJ; Trip MD; Prins MH; Kastelein JJ; Reitsma PH
    Atherosclerosis; 1998 Nov; 141(1):161-6. PubMed ID: 9863549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.
    Jacques PF; Bostom AG; Williams RR; Ellison RC; Eckfeldt JH; Rosenberg IH; Selhub J; Rozen R
    Circulation; 1996 Jan; 93(1):7-9. PubMed ID: 8616944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of 5,10-methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine concentration in patients with end-stage renal disease.
    Lee HA; Choi JS; Ha KS; Yang DH; Chang SK; Hong SY
    Am J Kidney Dis; 1999 Aug; 34(2):259-63. PubMed ID: 10430972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.
    Kaye JM; Stanton KG; McCann VJ; Vasikaran SD; Burke V; Taylor RR; van Bockxmeer FM
    Clin Sci (Lond); 2002 Jun; 102(6):631-7. PubMed ID: 12049616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylenetetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia, and cardiovascular diseases in chronic hemodialysis patients.
    Morimoto K; Haneda T; Okamoto K; Ishida H; Kikuchi K
    Nephron; 2002 Jan; 90(1):43-50. PubMed ID: 11744804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.
    Födinger M; Mannhalter C; Wölfl G; Pabinger I; Müller E; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1997 Aug; 52(2):517-23. PubMed ID: 9264011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.